Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU – Get Free Report) shares passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $217.76 and traded as low as $207.50. Direxion Daily S&P Biotech Bull 3X ETF shares last traded at $208.62, with a volume of 631,633 shares trading hands.
Direxion Daily S&P Biotech Bull 3X ETF Trading Up 7.3%
The business’s 50 day moving average is $251.97 and its two-hundred day moving average is $218.03.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3X ETF
Large investors have recently bought and sold shares of the stock. Ramsey Quantitative Systems acquired a new stake in shares of Direxion Daily S&P Biotech Bull 3X ETF in the 2nd quarter worth approximately $41,000. StoneX Group Inc. acquired a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the third quarter valued at approximately $241,000. Halbert Hargrove Global Advisors LLC acquired a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the third quarter valued at approximately $266,000. Valued Retirements Inc. bought a new stake in Direxion Daily S&P Biotech Bull 3X ETF during the second quarter worth approximately $454,000. Finally, Revere Asset Management Inc bought a new stake in Direxion Daily S&P Biotech Bull 3X ETF during the second quarter worth approximately $666,000.
Direxion Daily S&P Biotech Bull 3X ETF Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3X ETF
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3X ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3X ETF and related companies with MarketBeat.com's FREE daily email newsletter.
